{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:30:42Z","timestamp":1792438242233,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11481-010-9241-8","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T06:40:38Z","timestamp":1283755238000},"page":"28-40","source":"Crossref","is-referenced-by-count":17,"title":["Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases"],"prefix":"10.1007","volume":"6","author":[{"given":"Feng-Shiun","family":"Shie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing-Kang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"9241_CR1","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1073\/pnas.2237050100","volume":"100","author":"J Aarum","year":"2003","unstructured":"Aarum J, Sandberg K, Haeberlein SL, Persson MA (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA 100:15983\u201315988","journal-title":"Proc Natl Acad Sci USA"},{"key":"9241_CR2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","volume":"383","author":"AK Abbas","year":"1996","unstructured":"Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787\u2013793","journal-title":"Nature"},{"key":"9241_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","volume":"90","author":"S Akhondzadeh","year":"2007","unstructured":"Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179\u2013185","journal-title":"Schizophr Res"},{"key":"9241_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","volume":"26","author":"S Akhondzadeh","year":"2009","unstructured":"Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607\u2013611","journal-title":"Depress Anxiety"},{"key":"9241_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(98)00140-6","volume":"37","author":"K Akiyama","year":"1999","unstructured":"Akiyama K (1999) Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res 37:97\u2013106","journal-title":"Schizophr Res"},{"key":"9241_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuro.2005.10.003","volume":"27","author":"MY Aksenov","year":"2006","unstructured":"Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27:217\u2013228","journal-title":"Neurotoxicology"},{"key":"9241_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09540260701862037","volume":"20","author":"IC Anthony","year":"2008","unstructured":"Anthony IC, Bell JE (2008) The neuropathology of HIV\/AIDS. Int Rev Psychiatry 20:15\u201324","journal-title":"Int Rev Psychiatry"},{"key":"9241_CR8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789\u20131799","journal-title":"Neurology"},{"key":"9241_CR9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4049\/jimmunol.151.3.1175","volume":"151","author":"TM Aune","year":"1993","unstructured":"Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA (1993) Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 151:1175\u20131183","journal-title":"J Immunol"},{"key":"9241_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200923040-00003","volume":"23","author":"N Bassil","year":"2009","unstructured":"Bassil N, Grossberg GT (2009) Novel regimens and delivery systems in the pharmacological treatment of Alzheimer\u2019s disease. CNS Drugs 23:293\u2013307","journal-title":"CNS Drugs"},{"key":"9241_CR11","doi-asserted-by":"crossref","unstructured":"Ben Achour S, Pascual O (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int (in press)","DOI":"10.1016\/j.neuint.2010.02.013"},{"key":"9241_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2567.1997.00260.x","volume":"91","author":"N Benbernou","year":"1997","unstructured":"Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M (1997) Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91:361\u2013368","journal-title":"Immunology"},{"key":"9241_CR13","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.2741\/1427","volume":"9","author":"JR Berger","year":"2004","unstructured":"Berger JR, Avison M (2004) The blood brain barrier in HIV infection. Front Biosci 9:2680\u20132685","journal-title":"Front Biosci"},{"key":"9241_CR14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1109\/TNB.2007.908973","volume":"6","author":"CC Berry","year":"2007","unstructured":"Berry CC, de la Fuente JM, Mullin M, Chu SW, Curtis AS (2007) Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nanobioscience 6:262\u2013269","journal-title":"IEEE Trans Nanobioscience"},{"key":"9241_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.08.014.2009","volume":"3","author":"SD Bilbo","year":"2009","unstructured":"Bilbo SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3:1\u201314","journal-title":"Front Behav Neurosci"},{"key":"9241_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369","journal-title":"Nat Rev Neurosci"},{"key":"9241_CR17","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","volume":"92","author":"E Bonfoco","year":"1995","unstructured":"Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide\/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162\u20137166","journal-title":"Proc Natl Acad Sci USA"},{"key":"9241_CR18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-006-9023-5","volume":"1","author":"GA Cabral","year":"2006","unstructured":"Cabral GA (2006) Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol 1:280\u2013295","journal-title":"J Neuroimmune Pharmacol"},{"key":"9241_CR19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/3-540-26573-2_13","volume":"168","author":"GA Cabral","year":"2005","unstructured":"Cabral GA, Staab A (2005) Effects on the immune system. Handb Exp Pharmacol 168:385\u2013423","journal-title":"Handb Exp Pharmacol"},{"key":"9241_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(86)90040-5","volume":"17","author":"JR Calabrese","year":"1986","unstructured":"Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41\u201347","journal-title":"Psychiatry Res"},{"key":"9241_CR21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00006842-200105000-00007","volume":"63","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Dantzer R (2001a) Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med 63:376\u2013386","journal-title":"Psychosom Med"},{"key":"9241_CR22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4530(01)00030-0","volume":"26","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001b) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26:797\u2013808","journal-title":"Psychoneuroendocrinology"},{"key":"9241_CR23","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","volume":"119","author":"P Casassus","year":"2002","unstructured":"Casassus P, Caillat-Vigneron N, Martin A, Simon J, Gallais V, Beaudry P, Eclache V, Laroche L, Lortholary P, Raphael M, Guillevin L, Lortholary O (2002) Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol 119:1090\u20131097","journal-title":"Br J Haematol"},{"key":"9241_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0278-5846(01)00221-4","volume":"26","author":"CL Cazzullo","year":"2002","unstructured":"Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, Bosis S, Colombo F, Trabattoni D, Zagliani A, Clerici M (2002) Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 26:33\u201339","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9241_CR25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.wnl.0000240066.02404.e6","volume":"67","author":"G Chana","year":"2006","unstructured":"Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486\u20131489","journal-title":"Neurology"},{"key":"9241_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1185\/030079903125001938","volume":"19","author":"E Collantes-Estevez","year":"2003","unstructured":"Collantes-Estevez E, Fernandez-Perez C (2003) Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Curr Med Res Opin 19:402\u2013410","journal-title":"Curr Med Res Opin"},{"key":"9241_CR27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1750-3639.2002.tb00461.x","volume":"12","author":"MA Cosenza","year":"2002","unstructured":"Cosenza MA, Zhao ML, Si Q, Lee SC (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12:442\u2013455","journal-title":"Brain Pathol"},{"key":"9241_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","volume":"19","author":"LA Cysique","year":"2009","unstructured":"Cysique LA, Brew BJ (2009) Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review. Neuropsychol Rev 19:169\u2013185","journal-title":"Neuropsychol Rev"},{"key":"9241_CR29","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.2741\/2979","volume":"13","author":"NK Dhillon","year":"2008","unstructured":"Dhillon NK, Williams R, Callen S, Zien C, Narayan O, Buch S (2008) Roles of MCP-1 in development of HIV-dementia. Front Biosci 13:3913\u20133918","journal-title":"Front Biosci"},{"key":"9241_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/QAI.0b013e3181967354","volume":"50","author":"RM Donahoe","year":"2009","unstructured":"Donahoe RM, O\u2019Neil SP, Marsteller FA, Novembre FJ, Anderson DC, Lankford-Turner P, McClure HH (2009) Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque\/SIVsmm9 model. J Acquir Immune Defic Syndr 50:241\u2013249","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9241_CR31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.0900274","volume":"183","author":"H Dou","year":"2009","unstructured":"Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183:661\u2013669","journal-title":"J Immunol"},{"key":"9241_CR32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"L Drzyzga","year":"2006","unstructured":"Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20:532\u2013545","journal-title":"Brain Behav Immun"},{"key":"9241_CR33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157016206777709500","volume":"4","author":"R Dunfee","year":"2006","unstructured":"Dunfee R, Thomas ER, Gorry PR, Wang J, Ancuta P, Gabuzda D (2006) Mechanisms of HIV-1 neurotropism. Curr HIV Res 4:267\u2013278","journal-title":"Curr HIV Res"},{"key":"9241_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-2999(99)00142-9","volume":"372","author":"VA Edgar","year":"1999","unstructured":"Edgar VA, Sterin-Borda L, Cremaschi GA, Genaro AM (1999) Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur J Pharmacol 372:65\u201373","journal-title":"Eur J Pharmacol"},{"key":"9241_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","volume":"63","author":"A Eigler","year":"1998","unstructured":"Eigler A, Siegmund B, Emmerich U, Baumann KH, Hartmann G, Endres S (1998) Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol 63:101\u2013107","journal-title":"J Leukoc Biol"},{"key":"9241_CR36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3181\/0802-RM-59","volume":"233","author":"M Eilers","year":"2008","unstructured":"Eilers M, Roy U, Mondal D (2008) MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. Exp Biol Medicine (Maywood) 233:1149\u20131160","journal-title":"Exp Biol Medicine (Maywood)"},{"key":"9241_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2007.01.052","volume":"416","author":"A Familian","year":"2007","unstructured":"Familian A, Eikelenboom P, Veerhuis R (2007) Minocycline does not affect amyloid beta phagocytosis by human microglial cells. Neurosci Lett 416:87\u201391","journal-title":"Neurosci Lett"},{"key":"9241_CR38","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1523\/JNEUROSCI.4371-06.2007","volume":"27","author":"R Fan","year":"2007","unstructured":"Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, Van Nostrand WE (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27:3057\u20133063","journal-title":"J Neurosci"},{"key":"9241_CR39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.2008.08727.x","volume":"159","author":"SR Feldman","year":"2008","unstructured":"Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Li S, Dooley LT, Menter A (2008) Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol 159:704\u2013710","journal-title":"Br J Dermatol"},{"key":"9241_CR40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02265168","volume":"45","author":"I Ferjan","year":"1996","unstructured":"Ferjan I, Erjavec F (1996) Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants. Inflamm Res 45:141\u2013144","journal-title":"Inflamm Res"},{"key":"9241_CR41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.1114852","volume":"309","author":"L Fetler","year":"2005","unstructured":"Fetler L, Amigorena S (2005) Neuroscience. Brain under surveillance: the microglia patrol. Science 309:392\u2013393","journal-title":"Science"},{"key":"9241_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(05)64985-9","volume":"348","author":"NB Finter","year":"1996","unstructured":"Finter NB (1996) The naming of cats\u2014and alpha-interferons. Lancet 348:348\u2013349","journal-title":"Lancet"},{"key":"9241_CR43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","volume":"16","author":"H Friedman","year":"2003","unstructured":"Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16:209\u2013219","journal-title":"Clin Microbiol Rev"},{"key":"9241_CR44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1574-695X.2006.00097.x","volume":"47","author":"H Friedman","year":"2006","unstructured":"Friedman H, Pross S, Klein TW (2006) Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 47:330\u2013342","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9241_CR45","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007\u20132017","journal-title":"J Neurochem"},{"key":"9241_CR46","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","volume":"17","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Zhang W, Hong JS (2003) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson\u2019s disease. FASEB J 17:1954\u20131956","journal-title":"FASEB J"},{"key":"9241_CR47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0074-7742(02)52013-4","volume":"52","author":"F Gaughran","year":"2002","unstructured":"Gaughran F (2002) Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int Rev Neurobiol 52:275\u2013302","journal-title":"Int Rev Neurobiol"},{"key":"9241_CR48","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-4159.2004.02800.x","volume":"91","author":"RK Giri","year":"2004","unstructured":"Giri RK, Rajagopal V, Kalra VK (2004) Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91:1199\u20131210","journal-title":"J Neurochem"},{"key":"9241_CR49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918\u2013934","journal-title":"Cell"},{"key":"9241_CR50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1471-4159.2006.04211.x","volume":"99","author":"TE Golde","year":"2006","unstructured":"Golde TE (2006) Disease modifying therapy for AD? J Neurochem 99:689\u2013707","journal-title":"J Neurochem"},{"key":"9241_CR51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09540260701877894","volume":"20","author":"I Grant","year":"2008","unstructured":"Grant I (2008) Neurocognitive disturbances in HIV. Int Rev Psychiatry 20:33\u201347","journal-title":"Int Rev Psychiatry"},{"key":"9241_CR52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","volume":"72","author":"MM Halassa","year":"2010","unstructured":"Halassa MM, Haydon PG (2010) Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72:335\u2013355","journal-title":"Annu Rev Physiol"},{"key":"9241_CR53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","volume":"128","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O\u2019Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442\u20131453","journal-title":"Brain"},{"key":"9241_CR54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuint.2005.12.021","volume":"48","author":"L Hertz","year":"2006","unstructured":"Hertz L (2006) Glutamate, a neurotransmitter\u2014and so much more. A synopsis of Wierzba III. Neurochem Int 48:416\u2013425","journal-title":"Neurochem Int"},{"key":"9241_CR55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0361-9230(91)90117-3","volume":"27","author":"T Hori","year":"1991","unstructured":"Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, Katafuchi T (1991) Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27:309\u2013313","journal-title":"Brain Res Bull"},{"key":"9241_CR56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","volume":"400","author":"JT Huang","year":"1999","unstructured":"Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK (1999) Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase. Nature 400:378\u2013382","journal-title":"Nature"},{"key":"9241_CR57","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","volume":"345","author":"BA int' Veld","year":"2001","unstructured":"int' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease. N Engl J Med 345:1515\u20131521","journal-title":"N Engl J Med"},{"key":"9241_CR58","first-page":"2480","volume":"8","author":"M Islam","year":"2002","unstructured":"Islam M, Frye RF, Richards TJ, Sbeitan I, Donnelly SS, Glue P, Agarwala SS, Kirkwood JM (2002) Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. Clin Cancer Res 8:2480\u20132487","journal-title":"Clin Cancer Res"},{"key":"9241_CR59","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","volume":"22","author":"PT Jantzen","year":"2002","unstructured":"Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246\u20132254","journal-title":"J Neurosci"},{"key":"9241_CR60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2006.12.028","volume":"561","author":"J Jiang","year":"2007","unstructured":"Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood\u2013brain barrier damage. Eur J Pharmacol 561:54\u201362","journal-title":"Eur J Pharmacol"},{"key":"9241_CR61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1254\/jphs.94.325","volume":"94","author":"G Kang","year":"2004","unstructured":"Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, Chun W, Kim SS (2004) Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 94:325\u2013328","journal-title":"J Pharmacol Sci"},{"key":"9241_CR62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","volume":"5","author":"G Kenis","year":"2002","unstructured":"Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5:401\u2013412","journal-title":"Int J Neuropsychopharmacol"},{"key":"9241_CR63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","volume":"12","author":"RA Khairova","year":"2009","unstructured":"Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561\u2013578","journal-title":"Int J Neuropsychopharmacol"},{"key":"9241_CR64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0920-9964(99)00171-1","volume":"44","author":"YK Kim","year":"2000","unstructured":"Kim YK, Kim L, Lee MS (2000) Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophr Res 44:165\u2013175","journal-title":"Schizophr Res"},{"key":"9241_CR65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/00207450108986549","volume":"111","author":"DJ Kim","year":"2001","unstructured":"Kim DJ, Kim W, Yoon SJ, Go HJ, Choi BM, Jun TY, Kim YK (2001) Effect of risperidone on serum cytokines. Int J Neurosci 111:11\u201319","journal-title":"Int J Neurosci"},{"key":"9241_CR66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2007.10.018","volume":"1186","author":"SD Kim","year":"2007","unstructured":"Kim SD, Yang SI, Kim HC, Shin CY, Ko KH (2007) Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1\/2 activation and translocation of NF-kappaB in rat primary astrocyte. Brain Res 1186:12\u201320","journal-title":"Brain Res"},{"key":"9241_CR67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1471-4159.2009.06562.x","volume":"112","author":"J Kim","year":"2010","unstructured":"Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer\u2019s disease. J Neurochem 112:1415\u20131430","journal-title":"J Neurochem"},{"key":"9241_CR68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuron.2009.09.042","volume":"64","author":"SD Kraft-Terry","year":"2009","unstructured":"Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64:133\u2013145","journal-title":"Neuron"},{"key":"9241_CR69","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2007.08205.x","volume":"157","author":"R Krishnan","year":"2007","unstructured":"Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, Chiou CF, Patel V, Jahreis A (2007) Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96\u00a0weeks. Br J Dermatol 157:1275\u20131277","journal-title":"Br J Dermatol"},{"key":"9241_CR70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","volume":"157","author":"Z Kronfol","year":"2000","unstructured":"Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683\u2013694","journal-title":"Am J Psychiatry"},{"key":"9241_CR71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0893-133X(99)00150-5","volume":"23","author":"M Kubera","year":"2000","unstructured":"Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M (2000) Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 23:89\u201398","journal-title":"Neuropsychopharmacology"},{"key":"9241_CR72","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","volume":"11","author":"T Kukar","year":"2005","unstructured":"Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11:545\u2013550","journal-title":"Nat Med"},{"key":"9241_CR73","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.virol.2006.06.020","volume":"354","author":"R Kumar","year":"2006","unstructured":"Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A (2006) Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV\/SHIV-infected Indian rhesus macaques. Virology 354:192\u2013206","journal-title":"Virology"},{"key":"9241_CR74","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/01.aids.0000244208.49123.1b","volume":"20","author":"SL Letendre","year":"2006","unstructured":"Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I (2006) Lithium improves HIV-associated neurocognitive impairment. AIDS 20:1885\u20131888","journal-title":"AIDS"},{"key":"9241_CR75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65\u201370","journal-title":"Arch Neurol"},{"key":"9241_CR76","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/jnr.20692","volume":"82","author":"CS Lim","year":"2005","unstructured":"Lim CS, Jin DQ, Mok H, Oh SJ, Lee JU, Hwang JK, Ha I, Han JS (2005) Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. J Neurosci Res 82:831\u2013838","journal-title":"J Neurosci Res"},{"key":"9241_CR77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archpsyc.1983.01790040059008","volume":"40","author":"M Linnoila","year":"1983","unstructured":"Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 40:405\u2013406","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl","key":"9241_CR78","first-page":"S61","volume":"6","author":"SA Lipton","year":"2004","unstructured":"Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer\u2019s disease and other neurologic disorders. J Alzheimers Dis 6(Suppl):S61\u2013S74","journal-title":"J Alzheimers Dis"},{"key":"9241_CR79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jad.2004.04.002","volume":"82","author":"JM Loftis","year":"2004","unstructured":"Loftis JM, Hauser P (2004) The phenomenology and treatment of interferon-induced depression. J Affect Disord 82:175\u2013190","journal-title":"J Affect Disord"},{"key":"9241_CR80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/glia.1072","volume":"35","author":"LF Lue","year":"2001","unstructured":"Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J (2001) Inflammatory repertoire of Alzheimer\u2019s disease and nondemented elderly microglia in vitro. Glia 35:72\u201379","journal-title":"Glia"},{"key":"9241_CR81","doi-asserted-by":"crossref","first-page":"21453","DOI":"10.1074\/jbc.M414390200","volume":"280","author":"R Luna-Medina","year":"2005","unstructured":"Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Mart\u00ednez A, Perez-Castillo A (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem 280:21453\u201321462","journal-title":"J Biol Chem"},{"key":"9241_CR82","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11\u201338","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9241_CR83","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89:346\u2013351","journal-title":"Acta Psychiatr Scand"},{"key":"9241_CR84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","volume":"26","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY (1997) In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 26:221\u2013225","journal-title":"Schizophr Res"},{"key":"9241_CR85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0920-9964(00)00094-3","volume":"54","author":"M Maes","year":"2002","unstructured":"Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Altamura CA (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54:281\u2013291","journal-title":"Schizophr Res"},{"key":"9241_CR86","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1345\/aph.10172","volume":"35","author":"P Malek-Ahmadi","year":"2001","unstructured":"Malek-Ahmadi P (2001) Mood disorders associated with interferon treatment: theoretical and practical considerations. Ann Pharmacother 35:489\u2013495","journal-title":"Ann Pharmacother"},{"key":"9241_CR87","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","volume":"45","author":"A Martinez","year":"2002","unstructured":"Martinez A, Alonso M, Castro A, P\u00e9rez C, Moreno FJ (2002) First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer\u2019s disease. J Med Chem 45:1292\u20131299","journal-title":"J Med Chem"},{"key":"9241_CR88","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S1567-5769(03)00015-8","volume":"3","author":"K Masek","year":"2003","unstructured":"Masek K, Slansky J, Petrovicky P, Hadden JW (2003) Neuroendocrine immune interactions in health and disease. Int Immunopharmacol 3:1235\u20131246","journal-title":"Int Immunopharmacol"},{"key":"9241_CR89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00005792-198711000-00001","volume":"66","author":"JC McArthur","year":"1987","unstructured":"McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66:407\u2013437","journal-title":"Medicine (Baltimore)"},{"key":"9241_CR90","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","volume":"43","author":"JC McArthur","year":"1993","unstructured":"McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP et al (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245\u20132252","journal-title":"Neurology"},{"key":"9241_CR91","first-page":"S1","volume":"2","author":"PL McGeer","year":"1998","unstructured":"McGeer PL, McGeer EG (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord Suppl 2:S1\u2013S6","journal-title":"Alzheimer Dis Assoc Disord Suppl"},{"key":"9241_CR92","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2007","unstructured":"McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28:639\u2013647","journal-title":"Neurobiol Aging"},{"key":"9241_CR93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: a review of 17 epidemiologic studies. Neurology 47:425\u2013432","journal-title":"Neurology"},{"key":"9241_CR94","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","volume":"33","author":"F Meisner","year":"2008","unstructured":"Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, ter Meulen V, Koutsilieri E (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33:2228\u20132236","journal-title":"Neuropsychopharmacology"},{"key":"9241_CR95","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbi.2008.08.006","volume":"23","author":"AH Miller","year":"2009","unstructured":"Miller AH (2009) Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149\u2013158","journal-title":"Brain Behav Immun"},{"key":"9241_CR96","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/pr.107.07109","volume":"60","author":"DS Miller","year":"2008","unstructured":"Miller DS, Bauer B, Hartz AM (2008) Modulation of P-glycoprotein at the blood\u2013brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60:196\u2013209","journal-title":"Pharmacol Rev"},{"key":"9241_CR97","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.4049\/jimmunol.159.6.2994","volume":"159","author":"BB Mittleman","year":"1997","unstructured":"Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159:2994\u20132999","journal-title":"J Immunol"},{"key":"9241_CR98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79\u2013104","journal-title":"Mol Psychiatry"},{"key":"9241_CR99","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","volume":"375","author":"M Mogi","year":"2008","unstructured":"Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M (2008) Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun 375:446\u2013449","journal-title":"Biochem Biophys Res Commun"},{"key":"9241_CR100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-1781(97)00036-X","volume":"71","author":"P Monteleone","year":"1997","unstructured":"Monteleone P, Fabrazzo M, Tortorella A, Maj M (1997) Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res 71:11\u201317","journal-title":"Psychiatry Res"},{"key":"9241_CR101","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.58.9.585","volume":"58","author":"RJ Moots","year":"1999","unstructured":"Moots RJ, Al-Saffar Z, Hutchinson D, Golding SP, Young SP, Bacon PA, McLaughlin PJ (1999) Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis 58:585\u2013587","journal-title":"Ann Rheum Dis"},{"key":"9241_CR102","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1749-6632.2000.tb05410.x","volume":"917","author":"N Muller","year":"2000","unstructured":"Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ (2000) The immune system and schizophrenia. An integrative view. Ann NY Acad Sci 917:456\u2013467","journal-title":"Ann NY Acad Sci"},{"key":"9241_CR103","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","volume":"159","author":"N Muller","year":"2002","unstructured":"Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Moller HJ, Schwarz MJ (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029\u20131034","journal-title":"Am J Psychiatry"},{"key":"9241_CR104","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/13543784.13.8.1033","volume":"13","author":"N Muller","year":"2004","unstructured":"Muller N, Strassnig M, Schwarz MJ, Ulmschneider M, Riedel M (2004) COX-2 inhibitors as adjunctive therapy in schizophrenia. Expert Opin Investig Drugs 13:1033\u20131044","journal-title":"Expert Opin Investig Drugs"},{"key":"9241_CR105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680\u2013684","journal-title":"Mol Psychiatry"},{"key":"9241_CR106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","volume":"93","author":"L Nagy","year":"1998","unstructured":"Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229\u2013240","journal-title":"Cell"},{"key":"9241_CR107","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11481-008-9128-0","volume":"4","author":"MP Nair","year":"2009","unstructured":"Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ (2009) Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 4:129\u2013139","journal-title":"J Neuroimmune Pharmacol"},{"key":"9241_CR108","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1531-8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3","volume":"47","author":"A Nath","year":"2000","unstructured":"Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186\u2013194","journal-title":"Ann Neurol"},{"key":"9241_CR109","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09540260701861930","volume":"20","author":"A Nath","year":"2008","unstructured":"Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25\u201331","journal-title":"Int Rev Psychiatry"},{"key":"9241_CR110","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314\u20131318","journal-title":"Science"},{"key":"9241_CR111","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-5728(93)90174-W","volume":"45","author":"JG Norris","year":"1993","unstructured":"Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137\u2013145","journal-title":"J Neuroimmunol"},{"key":"9241_CR112","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2217\/nnm.09.38","volume":"4","author":"A Nowacek","year":"2009","unstructured":"Nowacek A, Gendelman HE (2009) NanoART, neuroAIDS and CNS drug delivery. Nanomedicine (Lond) 4:557\u2013574","journal-title":"Nanomedicine (Lond)"},{"key":"9241_CR113","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.609","volume":"19","author":"SM O'Brien","year":"2004","unstructured":"O'Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19:397\u2013403","journal-title":"Hum Psychopharmacol"},{"key":"9241_CR114","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2007.11.014","volume":"160","author":"SM O\u2019Brien","year":"2008","unstructured":"O\u2019Brien SM, Scully P, Dinan TG (2008) Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res 160:256\u2013262","journal-title":"Psychiatry Res"},{"key":"9241_CR115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(88)90283-1","volume":"23","author":"K Ohishi","year":"1988","unstructured":"Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O (1988) Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 23:326\u2013334","journal-title":"Biol Psychiatry"},{"key":"9241_CR116","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.smrv.2005.01.002","volume":"9","author":"MR Opp","year":"2005","unstructured":"Opp MR (2005) Cytokines and sleep. Sleep Med Rev 9:355\u2013364","journal-title":"Sleep Med Rev"},{"key":"9241_CR117","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.intimp.2005.10.004","volume":"6","author":"CU Pae","year":"2006","unstructured":"Pae CU, Yoon CH, Kim TS, Kim JJ, Park SH, Lee CU, Lee SJ, Lee C, Paik IH (2006) Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol 6:666\u2013671","journal-title":"Int Immunopharmacol"},{"key":"9241_CR118","doi-asserted-by":"crossref","first-page":"28736","DOI":"10.1074\/jbc.M304362200","volume":"278","author":"S Park","year":"2003","unstructured":"Park S, Geddes TJ, Javitch JA, Kuhn DM (2003) Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage? J Biol Chem 278:28736\u201328742","journal-title":"J Biol Chem"},{"key":"9241_CR119","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1440-1711.2001.01029.x","volume":"79","author":"N Petrovsky","year":"2001","unstructured":"Petrovsky N (2001) Towards a unified model of neuroendocrine\u2013immune interaction. Immunol Cell Biol 79:350\u2013357","journal-title":"Immunol Cell Biol"},{"key":"9241_CR120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","volume":"16","author":"T Pollmacher","year":"1996","unstructured":"Pollmacher T, Hinze-Selch D, Mullington J (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 16:403\u2013409","journal-title":"J Clin Psychopharmacol"},{"key":"9241_CR121","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1176\/ajp.154.12.1763","volume":"154","author":"T Pollmacher","year":"1997","unstructured":"Pollmacher T, Hinze-Selch D, Fenzel T, Kraus T, Schuld A, Mullington J (1997) Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry 154:1763\u20131765","journal-title":"Am J Psychiatry"},{"key":"9241_CR122","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801\u2013808","journal-title":"Biol Psychiatry"},{"key":"9241_CR123","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bcp.2004.05.042","volume":"68","author":"I Rahman","year":"2004","unstructured":"Rahman I, Marwick J, Kirkham P (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68:1255\u20131267","journal-title":"Biochem Pharmacol"},{"key":"9241_CR124","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1471-4159.2010.06634.x","volume":"113","author":"SR Rainey-Smith","year":"2010","unstructured":"Rainey-Smith SR, Andersson DA, Williams RJ, Rattray M (2010) Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration. J Neurochem 113:692\u2013703","journal-title":"J Neurochem"},{"key":"9241_CR125","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0024-3205(94)90029-9","volume":"54","author":"R Ramchand","year":"1994","unstructured":"Ramchand R, Wei J, Ramchand CN, Hemmings GP (1994) Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment. Life Sci 54:1579\u20131584","journal-title":"Life Sci"},{"key":"9241_CR126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1\u201347","journal-title":"J Gen Virol"},{"key":"9241_CR127","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpsychires.2005.11.007","volume":"41","author":"M Riedel","year":"2007","unstructured":"Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Moller HJ, Muller N (2007) Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41:3\u20137","journal-title":"J Psychiatr Res"},{"key":"9241_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","volume":"10","author":"JD Rippeth","year":"2004","unstructured":"Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1\u201314","journal-title":"J Int Neuropsychol Soc"},{"key":"9241_CR129","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/brbi.2001.0648","volume":"15","author":"M Rothermundt","year":"2001","unstructured":"Rothermundt M, Arolt V, Bayer TA (2001) Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 15:319\u2013339","journal-title":"Brain Behav Immun"},{"key":"9241_CR130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11481-005-9009-8","volume":"1","author":"S Roy","year":"2006","unstructured":"Roy S, Wang J, Kelschenbach J, Koodie L, Martin J (2006) Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol 1:77\u201389","journal-title":"J Neuroimmune Pharmacol"},{"key":"9241_CR131","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/art.27304","volume":"62","author":"S Sacre","year":"2010","unstructured":"Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R (2010) Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit Toll-like receptors. Arthritis Rheum 62:683\u2013693","journal-title":"Arthritis Rheum"},{"key":"9241_CR132","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1056\/NEJM199406303302609","volume":"330","author":"CB Saper","year":"1994","unstructured":"Saper CB, Breder CD (1994) The neurologic basis of fever. N Engl J Med 330:1880\u20131886","journal-title":"N Engl J Med"},{"key":"9241_CR133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0736-5748(94)00076-F","volume":"13","author":"M Sawada","year":"1995","unstructured":"Sawada M, Suzumura A, Marunouchi T (1995) Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13:253\u2013264","journal-title":"Int J Dev Neurosci"},{"key":"9241_CR134","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","volume":"57","author":"JU Scher","year":"2009","unstructured":"Scher JU, Pillinger MH (2009) The anti-inflammatory effects of prostaglandins. J Investig Med 57:703\u2013708","journal-title":"J Investig Med"},{"key":"9241_CR135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","volume":"66","author":"G Schifitto","year":"2006","unstructured":"Schifitto G, Peterson DR, Zhong J, Ni H, Cruttenden K, Gaugh M, Gendelman HE, Boska M, Gelbard H (2006) Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 66:919\u2013921","journal-title":"Neurology"},{"key":"9241_CR136","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","volume":"21","author":"G Schifitto","year":"2007","unstructured":"Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA (2007) Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21:1877\u20131886","journal-title":"AIDS"},{"key":"9241_CR137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1022397704922","volume":"28","author":"A Schousboe","year":"2003","unstructured":"Schousboe A (2003) Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem Res 28:347\u2013352","journal-title":"Neurochem Res"},{"key":"9241_CR138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuint.2003.11.001","volume":"45","author":"A Schousboe","year":"2004","unstructured":"Schousboe A, Sarup A, Bak LK, Waagepetersen HS, Larsson OM (2004) Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem Int 45:521\u2013527","journal-title":"Neurochem Int"},{"key":"9241_CR139","first-page":"164","volume":"43","author":"A Schuld","year":"2000","unstructured":"Schuld A, Kraus T, Haack M, Hinze-Selch D, Kuhn M, Pollmacher T (2000) Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res 43:164\u2013166","journal-title":"Schizophr Res"},{"key":"9241_CR140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316\u2013318","journal-title":"Science"},{"key":"9241_CR141","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"9241_CR142","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0024-3205(99)00430-0","volume":"65","author":"Y Shen","year":"1999","unstructured":"Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE (1999) Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci 65:1773\u20131786","journal-title":"Life Sci"},{"key":"9241_CR143","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2174\/092986707782359981","volume":"14","author":"FS Shie","year":"2007","unstructured":"Shie FS, Woltjer RL (2007) Manipulation of microglial activation as a therapeutic strategy in Alzheimer\u2019s disease. Curr Med Chem 14:2865\u20132871","journal-title":"Curr Med Chem"},{"key":"9241_CR144","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11096-005-1319-7","volume":"27","author":"S Sleijfer","year":"2005","unstructured":"Sleijfer S, Bannink M, Van Gool AR, Kruit WH, Stoter G (2005) Side effects of interferon-alpha therapy. Pharm World Sci 27:423\u2013431","journal-title":"Pharm World Sci"},{"key":"9241_CR145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(98)00025-1","volume":"49","author":"C Song","year":"1998","unstructured":"Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49:211\u2013219","journal-title":"J Affect Disord"},{"key":"9241_CR146","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1523\/JNEUROSCI.09-06-02066.1989","volume":"9","author":"C Speciale","year":"1989","unstructured":"Speciale C, Hares K, Schwarcz R, Brookes N (1989) High-affinity uptake of l-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes. J Neurosci 9:2066\u20132072","journal-title":"J Neurosci"},{"key":"9241_CR147","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","volume":"164","author":"M Stolina","year":"2000","unstructured":"Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM (2000) Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 164:361\u2013370","journal-title":"J Immunol"},{"key":"9241_CR148","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuint.2009.01.025","volume":"55","author":"LA Struzy\u0144ska","year":"2009","unstructured":"Struzy\u0144ska LA (2009) Glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters. Neurochem Int 55:151\u2013156","journal-title":"Neurochem Int"},{"key":"9241_CR149","first-page":"30","volume":"21","author":"G Szabo","year":"1997","unstructured":"Szabo G (1997) Alcohol\u2019s contribution to compromised immunity. Alcohol Health Res World 21:30\u201341","journal-title":"Alcohol Health Res World"},{"key":"9241_CR150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0361-9230(01)00428-2","volume":"54","author":"J Szelenyi","year":"2001","unstructured":"Szelenyi J (2001) Cytokines and the central nervous system. Brain Res Bull 54:329\u2013338","journal-title":"Brain Res Bull"},{"key":"9241_CR151","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.euroneuro.2007.03.010","volume":"17","author":"M Taler","year":"2007","unstructured":"Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A, Weizman A (2007) Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 17:774\u2013780","journal-title":"Eur Neuropsychopharmacol"},{"key":"9241_CR152","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.intimp.2007.12.003","volume":"8","author":"M Taler","year":"2008","unstructured":"Taler M, Bar M, Korob I, Lomnitski L, Baharav E, Grunbaum-Novak N, Weizman A, Gil-Ad I (2008) Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. Int Immunopharmacol 8:526\u2013533","journal-title":"Int Immunopharmacol"},{"key":"9241_CR153","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1523\/JNEUROSCI.4456-04.2005","volume":"25","author":"DL Taylor","year":"2005","unstructured":"Taylor DL, Jones F, Kubota ES, Pocock JM (2005) Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25:2952\u20132964","journal-title":"J Neurosci"},{"key":"9241_CR154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v13n02_01","volume":"13","author":"PV Thadani","year":"1994","unstructured":"Thadani PV, Sharp C (1994) Drugs of abuse and dysfunction of neuroendocrine and immune systems: the importance of animal research. J Addict Dis 13:1\u20138","journal-title":"J Addict Dis"},{"key":"9241_CR155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/brbi.1995.1026","volume":"9","author":"AV Turnbull","year":"1995","unstructured":"Turnbull AV, Rivier C (1995) Regulation of the HPA axis by cytokines. Brain Behav Immun 9:253\u2013275","journal-title":"Brain Behav Immun"},{"key":"9241_CR156","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29\u201335","journal-title":"Lancet"},{"key":"9241_CR157","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrn2274","volume":"8","author":"AV Tzingounis","year":"2007","unstructured":"Tzingounis AV, Wadiche JI (2007) Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci 8:935\u2013947","journal-title":"Nat Rev Neurosci"},{"key":"9241_CR158","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/381975","volume":"38","author":"A Urbina","year":"2004","unstructured":"Urbina A, Jones K (2004) Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 38:890\u2013894","journal-title":"Clin Infect Dis"},{"key":"9241_CR159","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.antiviral.2008.12.013","volume":"82","author":"L Varatharajan","year":"2009","unstructured":"Varatharajan L, Thomas SA (2009) The transport of anti-HIV drugs across blood\u2013CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res 82:A99\u2013A109","journal-title":"Antiviral Res"},{"key":"9241_CR160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2000.740457.x","volume":"74","author":"L Vitkovic","year":"2000","unstructured":"Vitkovic L, Bockaert J, Jacque C (2000) \u201cInflammatory\u201dcytokines: neuromodulators in normal brain? J Neurochem 74:457\u2013471","journal-title":"J Neurochem"},{"key":"9241_CR161","first-page":"11","volume":"29","author":"MC Wichers","year":"2004","unstructured":"Wichers MC, Maes M (2004) The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29:11\u201317","journal-title":"J Psychiatry Neurosci"},{"key":"9241_CR162","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1744-6163.2008.00188.x","volume":"44","author":"DR Wilson","year":"2008","unstructured":"Wilson DR, Warise L (2008) Cytokines and their role in depression. Perspect Psychiatr Care 44:285\u2013289","journal-title":"Perspect Psychiatr Care"},{"key":"9241_CR163","first-page":"311","volume":"43","author":"M Wojtera","year":"2005","unstructured":"Wojtera M, Sikorska B, Sobow T, Liberski PP (2005) Microglial cells in neurodegenerative disorders. Folia Neuropathol 43:311\u2013321","journal-title":"Folia Neuropathol"},{"key":"9241_CR164","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","volume":"34","author":"Z Xia","year":"1996","unstructured":"Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34:27\u201337","journal-title":"Immunopharmacology"},{"key":"9241_CR165","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11481-009-9174-2","volume":"4","author":"A Yadav","year":"2009","unstructured":"Yadav A, Collman RG (2009) CNS inflammation and macrophage\/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430\u2013447","journal-title":"J Neuroimmune Pharmacol"},{"key":"9241_CR166","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892\u20135901","journal-title":"J Biol Chem"},{"key":"9241_CR167","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/13550289809114228","volume":"4","author":"L Zhang","year":"1998","unstructured":"Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M (1998) Cocaine opens the blood\u2013brain barrier to HIV-1 invasion. J Neurovirol 4:619\u2013626","journal-title":"J Neurovirol"},{"key":"9241_CR168","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","volume":"65","author":"XY Zhang","year":"2004","unstructured":"Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (2004) Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 65:940\u2013947","journal-title":"J Clin Psychiatry"},{"key":"9241_CR169","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00019052-199708000-00007","volume":"10","author":"J Zheng","year":"1997","unstructured":"Zheng J, Gendelman HE (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10:319\u2013325","journal-title":"Curr Opin Neurol"},{"key":"9241_CR170","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","volume":"293","author":"MC Zink","year":"2005","unstructured":"Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:2003\u20132011","journal-title":"JAMA"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-010-9241-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-010-9241-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T05:45:57Z","timestamp":1685771157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-010-9241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9241"],"URL":"https:\/\/doi.org\/10.1007\/s11481-010-9241-8","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}